| Field Name |
Data Description |
| Test Name |
Epstein-Barr Virus (EBV) Viral Capsid Antigen IgA |
| Code |
EBV Ab to Viral Capsid Ag. IgA. |
|
CPT Code |
86665 |
| Last Modified |
4/18/2018 1:56:00 PM |
| Test Name |
EBVAbCapAglgA. |
| Synonyms |
VAC, antibody, epstein barr virus, EBV Ag, antibodies |
| Patient Preparation |
|
| Spec. Requirements |
Blood |
| Tube |
Gold or Red |
| Collection Volume |
3.5 mL Gold or 4.0 mL Red |
| Storage |
Regrigerate 2 weeks, Frozen 1 year, Ambient 2 days |
| Routine TAT |
1-3 Days |
| STAT TAT |
N/A |
| Days Test Performed |
|
| Performed by BHS |
None |
| See Availability |
|
| Reference Lab |
LabCorp of America |
| Reference Lab Code |
829532 EBV Ab to Viral Capsid Ag, IgA |
| Clinical Use |
VCA-IgA antibodies are useful for screening high risk populations for nasopharyngeal carcinoma. VCA-IgA antibody screening combined with detection of high titer EA IgA antibodies is useful in identifying early stage nasopharyngeal carcinoma. |
| Reference Range |
EBV Viral Capsid Antigen IgA Abs: < 1:10 titer |
| Critical Value |
|
|
|
| Testing Sample Type |
Serum |
| Min Lab Testing Volume |
0.4 mL |
| Special Handling |
Collection:Serum should be separated from cells within 2 hours of venipuncture. Send serum in a plastic transport tube. |
| Lab Notes |
Testing referred to ARUP Y8#51626 |
| Methodology |
EIA - Enzyme Immunoassay |
| Limitations |
For research use only |
